Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules

Abstract

Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder that is characterized by large platelets that lack α-granules. Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. Proteomic analysis of sucrose-gradient subcellular fractions of platelets indicated that NBEAL2 localizes to the dense tubular system (endoplasmic reticulum) in platelets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cellular studies of GPS.

Similar content being viewed by others

References

  1. Rendu, F. & Brohard-Bohn, B. Platelets 12, 261–273 (2001).

    Article  CAS  Google Scholar 

  2. Maynard, D.M., Heijnen, H.F., Horne, M.K., White, J.G. & Gahl, W.A. J. Thromb. Haemost. 5, 1945–1955 (2007).

    Article  CAS  Google Scholar 

  3. Weiss, H.J. et al. Blood 54, 1296–1319 (1979).

    CAS  PubMed  Google Scholar 

  4. Gunay-Aygun, M., Huizing, M. & Gahl, W.A. Semin. Thromb. Hemost. 30, 537–547 (2004).

    Article  CAS  Google Scholar 

  5. Nurden, A.T. & Nurden, P. Blood Rev. 21, 21–36 (2007).

    Article  CAS  Google Scholar 

  6. Gunay-Aygun, M. et al. Blood 116, 4990–5001 (2010).

    Article  CAS  Google Scholar 

  7. Raccuglia, G. Am. J. Med. 51, 818–828 (1971).

    Article  CAS  Google Scholar 

  8. White, J.G. Am. J. Pathol. 95, 445–462 (1979).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Breton-Gorius, J., Vainchenker, W., Nurden, A., Levy-Toledano, S. & Caen, J. Am. J. Pathol. 102, 10–19 (1981).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Maynard, D.M., Heijnen, H.F., Gahl, W.A. & Gunay-Aygun, M. J. Thromb. Haemost. 8, 1786–1796 (2010).

    Article  CAS  Google Scholar 

  11. Hyman, T. et al. Br. J. Haematol. 122, 142–149 (2003).

    Article  CAS  Google Scholar 

  12. Jiang, F., Jia, Y. & Cohen, I. Blood 99, 3579–3584 (2002).

    Article  CAS  Google Scholar 

  13. Malara, A. et al. Blood 117, 2476–2483 (2010).

    Article  Google Scholar 

  14. Wang, N., Wu, W.I. & De Lozanne, A. J. Cell. Biochem. 86, 561–570 (2002).

    Article  CAS  Google Scholar 

  15. Kaplan, J., De Domenico, I. & Ward, D.M. Curr. Opin. Hematol. 15, 22–29 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all of our subjects with GPS and their families for their cooperation; the NIH Intramural Sequencing Center for performing the whole-exome sequencing and analysis; A. Nurden for the French patient; I. Bernardini and R. Fisher for technical assistance; H. Edwards, L. Riley, K. Patzel, P. Tanpaiboon, J. Chezar and J. Manaster for DNA sequencing assistance; T. Markello for the SNP array; and I. Maric, S. Gucer and I. Kuzu for assistance with bone marrow slides. This study was supported by the Intramural Research Programs of the National Human Genome Research Institute and the NIH Clinical Center and by the Israeli Ministry of Justice; Izvonot Fund, grants 84/2004, 85/2004 and 9090-25/2007 to T.C.F.-Z.

Author information

Authors and Affiliations

Authors

Contributions

M.G.-A. is the principal investigator of clinical trials NCT00069680 (Genetic Analysis of Gray Platelet Syndrome) and NCT00086476 (Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles); M.G.-A. wrote the manuscript and cultured megakaryocytes; M.G.-A., W.A.G. and T.C.F.-Z. designed and supervised research; M.G.-A., T.C.F.-Z. and T.V. analyzed clinical and molecular data; T.C.F.-Z., is the principal investigator of the Israeli protocol 'Clinical and Genetic Analysis of Gray Platelet Syndrome'; W.A.G. is the principal investigator of clinical trial NCT00369421 (Diagnosis and Treatment of Patients With Inborn Errors of Metabolism) and accountable investigator of clinical trial NCT00069680 (Genetic Analysis of Gray Platelet Syndrome); M.G.-A., T.V., T.C.F.-Z., J.C.M., C.F.B. and M.H. supervised DNA sequencing; M.G.-A., T.V., Y.Z.-E., F.G., M.C., M.K., C.F.B., N.K., Y.H., K.B., R.K. and P.C., performed DNA sequencing; M.G.-A., T.C.F.-Z., F.G., M.C., M.K., N.K., R.K., Y.A., M.A., A.S.F., B.E.K., K.J. and J.G.W. recruited patients and provided clinical data; J.G.W. performed electron microscopy; D.M. performed proteomic analysis; H.D. cultured fibroblasts; T.C.F.-Z., T.V., Y.Z.-E., F.G., M.C., M.K., C.F.B., N.K., Y.H., D.M., H.D., K.B., R.K., Y.A., M.A., A.S.F., B.E.K., K.J., P.C., J.C.M., J.G.W., M.H. and W.A.G. participated in preparing the manuscript.

Corresponding author

Correspondence to Meral Gunay-Aygun.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4, Supplementary Table 1 and Supplementary Methods (PDF 2002 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gunay-Aygun, M., Falik-Zaccai, T., Vilboux, T. et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet 43, 732–734 (2011). https://doi.org/10.1038/ng.883

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.883

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing